tpan.com Quick Links

2004 HIV Drug Guide

2004 HIV Services Directory

Positively Aware

Positively Aware en Español

Special Positive Parenting Section

Positive Women Speak Out About HIV and Pregnancy

 

Originally published in the Spring/Summer 2003 issue of Juice, the newsletter of S.M.A.R.T. (Sisterhood Mobilized for AIDS/HIV Research & Treatment)

A couple of Saturdays ago I had the opportunity to lead a roundtable discussion about HIV and pregnancy with women from S.M.A.R.T. University, Inc. The discussion lasted only an hour, but the issues covered during that hour spanned generations. As a trainer in HIV/AIDS, I have conducted numerous trainings on HIV and pregnancy, but never have I been as inspired as I was that Saturday morning.

As anyone who follows HIV/AIDS or issues facing HIV positive women knows, HIV can be transferred to the unborn child of an HIV positive mother during pregnancy, labor or childbirth. The rate of mother-to-child transmission of HIV is approximately 25% without treatment. AIDS Clinical Trial Group (ACTG) 076, taught us that administering zidovudine (AZT) to the mother during pregnancy, labor and delivery, and administering it to the child for the first six weeks of life, reduced the risk of perinatal transmission to 8% or lower. ACTG 076 resulted in significant changes in the management of pregnant women and newborns, particularly in New York where state law mandated testing all newborns for HIV. As recently as a few weeks ago, federal officials proposed testing all pregnant women for HIV as a routine part of obstetric care. Without minimizing the importance of the reduction of perinatal transmission, and acknowledging it as a critical step in the prevention of HIV, our discussion extended beyond a mother passing the virus to her child to examine the numerous psychological and physical aspects of HIV in pregnancy.

An HIV positive woman in the United States is very likely to be in her childbearing years. According to the HIV/AIDS Surveillance Report, (December 2001), 115,324 women or 80% of all women infected in the United States are between the ages of 13 and 44. The reduction in perinatal transmission is very exciting. Excitement alone, however, is not enough to support an HIV positive woman’s decision to have children. She needs the support of family and friends, a broad knowledge of HIV/AIDS, and the cooperative care of a knowledgeable, HIV savvy obstetrician-gynecologist (OB-GYN).

The women in our discussion recalled the days when physicians recommended abortion as the best option for an HIV positive pregnant woman. Twenty-plus years into the epidemic, not all obstetricians are equipped to provide quality care to HIV positive women. As a result, women must be prepared to seek out a physician who:

  • is committed to the care of HIV positive pregnant women,
  • is trained in high-risk HIV obstetric care, and
  • believes in encouraging patients to participate in their own care.

Women must have a working knowledge of HIV and be willing to participate in their own care. This is very important for a woman managing HIV and pregnancy. For example, something as common in pregnancy as morning sickness, or loss of appetite can be severely complicated by HIV. Understanding adherence to Highly Active Antiretroviral Therapy (HAART), drug resistance and other problems is necessary to minimize the possibility of drug resistance in the mother, in the newborn if infected, or both.

HIV/hepatitis C co-infection in pregnancy was of particular interest to our group. The risk of transmission of hepatitis C to an infant increases if the mother is HIV positive. In a woman with HIV/hepatitis C co-infection, liver function tests should be followed on a regular basis. Interferon therapy, the treatment for hepatitis C should be discontinued during pregnancy because the affect on the fetus is unknown, and interferon and Ribavarin combination therapy has been associated with birth defects and, therefore, should not be used during pregnancy or breastfeeding.

Other topics of concern were domestic violence, bloodless C-sections (an elective C-section during which the mother’s blood vessels are cauterized to prevent the baby from being exposed to the mother’s blood), HAART, the long-term effect of HAART on children, substance use/abuse, the right of a mother to refuse HIV medications for her newborn, hyperglycemia and diabetes. The exacerbation of existing diabetes mellitus has been associated with the administration of protease inhibitors. As pregnancy itself is a risk factor for hyperglycemia, it is unclear if protease inhibitors lead to pregnancy-associated hyperglycemia in HIV positive women.

Discussing these topics reaffirmed our beliefs that an obstetrician with detailed and current experience treating women with HIV, or a team of doctors, one of whom is an HIV specialist is the best choice for a woman managing pregnancy and HIV. The women of SMART recognize that advocacy, empowering women to negotiate quality, culturally-sensitive health care for themselves and their children, and education are the best ways to assist women in their search for locating this kind of care. Poor women of color in their childbearing years, who account for 80% of the infected women in the United States, are not likely to be prepared to negotiate for themselves, hence the need for advocacy and legal organizations that will assist a woman in negotiating her benefits and her care.

Taking a look at adolescents, we discussed the importance of older women living with the virus to mentor and encourage younger positive women as they come face-to-face with their own sexuality. A wonderful connection was made when one member of the group, who focuses her volunteer efforts and mentoring solely on her peers—women over fifty with HIV, decided that she wanted to seek opportunities to nurture younger women living with the virus.

While the number of individuals infected with HIV from birth is quite low, our group had quite a bit of experience working with children infected at birth. Other issues that developed out of our conversation about children infected at birth (not exclusively) were:

• Disclosing HIV status to children infected at birth

This was a very sensitive topic. We all knew of cases where the children were approaching adolescence but were not told their HIV status or that of their mothers. There were no absolute answers to when a child should be told they are HIV positive. We concluded that the time should depend on the developmental level of the child, the parent’s comfort level, communication skills, support and a host of other factors. Disclosure to the child was a difficult issue, and uncovered the underlying guilt that many mothers felt for having infected their own child with a deadly virus. The guilt, if not dealt with, we felt, would in turn affect when disclosure takes place, and how the child receives the message.

• Disclosure to partners

Disclosing one’s HIV status to their partner was another area of concern. This is a hefty task for a person of any sex and any age. A young woman faced with this challenge without support may not be able to handle it. The fear of abuse, violence or loss of her partner may be so overwhelming that she may avoid disclosing to her partner at all.

• Women in prison

The treatment and care of HIV positive pregnant women in prison really pulled at our heartstrings. Pregnancy in prison is convoluted enough. HIV presents another tremendous burden on a woman concerned about the safety and health of her unborn child. The treatment and care of HIV positive pregnant women as discussed earlier requires highly skilled high-risk OB-GYN care. Advocating for this type of care in prison is problematic at best.

• Women over fifty

While this is not a group that we usually think about when considering HIV and pregnancy, it cannot be overlooked that grandmothers are often involved with the care of the infants born to HIV positive women, and whether infected or not, the child’s mother will need support. We should not overlook the fact that there are 14,117 women over fifty infected with HIV, or 9% of all women infected with the virus.

• Legal Issues

Advances in HIV treatment has resulted in longer life spans and improved quality of life for persons with HIV/AIDS. Notwithstanding this success, estate planning and establishing guardians or standby guardians for the children of HIV positive parents will always be important. Legal services can be invaluable in the event that assistance is needed in obtaining entitlements, life insurance, housing, credit, treatment of substance use, refusing treatment for children, etc.

There is a critical need for a focus on pregnant women with HIV. Women need support at every stage of life, from birth to their golden years, and when considering HIV and pregnancy, no stone can be left unturned. It wasn’t that long ago that a woman diagnosed with HIV looked forward only to permanency planning, guardianship issues, and preparation for prolonged illness and death.

With the support and advocacy of other women, organizations, and dedicated physicians, a woman can plan for a healthy life filled with many options and hope.

This was one Saturday morning that I will not soon forget. I am grateful for the opportunity to have been involved in this discussion. During roundtable sessions like these, ideas are born, organizations are made, networking occurs, and support systems that are so desperately needed are created. Hopefully more of my Saturday mornings will be as dynamic and prosperous.

Ms. Cathleen Williams is a senior trainer with Cicatelli Associates Inc. in New York City. She is a licensed attorney in the state of New York, and is also a Registered Nurse with an extensive background in clinical nursing in HIV/AIDS, critical care, quality improvement case management of special disease populations, and administrative nursing.

Ms. Williams is a member of the New York Chapter of the Association for Nurses in AIDS Care, and still volunteers as a speaker for community, youth and women’s organizations.

| Positively Aware | 2004 HIV Drug Guide | Positively Aware en español |

|Chicago Area HIV Services Directory | Publications Home |

| Publications | Client Services | MOCHA | Events | Helping TPAN |

| Contacts and Staff | About TPAN | Ask TPAN | Links | TPAN Home |